» Articles » PMID: 18188180

A Selective PIKfyve Inhibitor Blocks PtdIns(3,5)P(2) Production and Disrupts Endomembrane Transport and Retroviral Budding

Overview
Journal EMBO Rep
Specialty Molecular Biology
Date 2008 Jan 12
PMID 18188180
Citations 153
Authors
Affiliations
Soon will be listed here.
Abstract

Phosphoinositides have crucial roles in cellular controls, many of which have been established through the use of small-molecule inhibitors. Here, we describe YM201636, a potent inhibitor of the mammalian class III phosphatidylinositol phosphate kinase PIKfyve, which synthesizes phosphatidylinositol 3,5-bisphosphate. Acute treatment of cells with YM201636 shows that the PIKfyve pathway is involved in the sorting of endosomal transport, with inhibition leading to the accumulation of a late endosomal compartment and blockade of retroviral exit. Inhibitor specificity is shown by the use of short interfering RNA against the target, as well as by rescue with the drug-resistant yeast orthologue Fab1. We concluded that the phosphatidylinositol 3,5-bisphosphate pathway is integral to endosome formation, determining morphology and cargo flux.

Citing Articles

Oncogenic RAS induces a distinctive form of non-canonical autophagy mediated by the P38-ULK1-PI4KB axis.

Wang X, Li S, Lin S, Han Y, Zhan T, Huang Z Cell Res. 2025; .

PMID: 40055523 DOI: 10.1038/s41422-025-01085-9.


Selective Termination of Autophagy-Dependent Cancers.

Roy A, DePamphilis M Cells. 2024; 13(13.

PMID: 38994949 PMC: 11240546. DOI: 10.3390/cells13131096.


Stress-induced microautophagy is coordinated with lysosome biogenesis and regulated by PIKfyve.

Klein A, Petruzzi K, Lee C, Overholtzer M Mol Biol Cell. 2024; 35(5):ar70.

PMID: 38536415 PMC: 11151102. DOI: 10.1091/mbc.E23-08-0332.


PIKFYVE inhibitors trigger interleukin-24-dependent cell death of autophagy-dependent melanoma.

Roy A, Chakraborty A, DePamphilis M Mol Oncol. 2024; 18(4):988-1011.

PMID: 38414326 PMC: 10994231. DOI: 10.1002/1878-0261.13607.


Unexpected inhibition of the lipid kinase PIKfyve reveals an epistatic role for p38 MAPKs in endolysosomal fission and volume control.

Wible D, Parikh Z, Cho E, Chen M, Jeter C, Mukhopadhyay S Cell Death Dis. 2024; 15(1):80.

PMID: 38253602 PMC: 10803372. DOI: 10.1038/s41419-024-06423-0.


References
1.
Nicot A, Fares H, Payrastre B, Chisholm A, Labouesse M, Laporte J . The phosphoinositide kinase PIKfyve/Fab1p regulates terminal lysosome maturation in Caenorhabditis elegans. Mol Biol Cell. 2006; 17(7):3062-74. PMC: 1483040. DOI: 10.1091/mbc.e05-12-1120. View

2.
Lindmo K, Stenmark H . Regulation of membrane traffic by phosphoinositide 3-kinases. J Cell Sci. 2006; 119(Pt 4):605-14. DOI: 10.1242/jcs.02855. View

3.
Hayakawa M, Kaizawa H, Moritomo H, Koizumi T, Ohishi T, Okada M . Synthesis and biological evaluation of 4-morpholino-2-phenylquinazolines and related derivatives as novel PI3 kinase p110alpha inhibitors. Bioorg Med Chem. 2006; 14(20):6847-58. DOI: 10.1016/j.bmc.2006.06.046. View

4.
Rutherford A, Traer C, Wassmer T, Pattni K, Bujny M, Carlton J . The mammalian phosphatidylinositol 3-phosphate 5-kinase (PIKfyve) regulates endosome-to-TGN retrograde transport. J Cell Sci. 2006; 119(Pt 19):3944-57. PMC: 1904490. DOI: 10.1242/jcs.03153. View

5.
Hayakawa M, Kaizawa H, Moritomo H, Koizumi T, Ohishi T, Yamano M . Synthesis and biological evaluation of pyrido[3',2':4,5]furo[3,2-d]pyrimidine derivatives as novel PI3 kinase p110alpha inhibitors. Bioorg Med Chem Lett. 2007; 17(9):2438-42. DOI: 10.1016/j.bmcl.2007.02.032. View